HOSP stands against the most recent restrictions implemented by Johnson & Johnson
HOSP stands against the most recent restrictions implemented by Johnson & Johnson that will severely limit access to 340B discounts for safety net providers. These enhanced restrictions place undue burden on hospitals through new reporting requirements for owned pharmacies. They also significantly limit access to 340B discounts on some of the most costly medications by [...]